Patterns of care for lung cancer in radiation oncology departments of Turkey

International Journal of Radiation Oncology, Biology, Physics
Ayşe Nur DemiralMünir Kinay

Abstract

To determine the patterns of care for lung cancer in Turkish radiation oncology centers. Questionnaire forms from 21 of 24 (87.5%) centers that responded were evaluated. The most frequent histology was non-small cell lung cancer (NSCLC) (81%). The most common postoperative radiotherapy (RT) indications were close/(+) surgical margins (95%) and presence of pN2 disease (91%). The most common indications for postoperative chemotherapy (CHT) were ">/= IB" disease (19%) and the presence of pN2 disease (19%). In Stage IIIA potentially resectable NSCLC, the most frequent treatment approach was neoadjuvant concomitant chemoradiotherapy (CHRT) (57%). In Stage IIIA unresectable and Stage IIIB disease, the most frequent approach was definitive concomitant CHRT (91%). In limited SCLC, the most common treatment approach was concomitant CHRT with cisplatin+etoposide for cycles 1-3, completion of CHT to cycles 4-6, and finally prophylactic cranial irradiation in patients with complete response (71%). Six cycles of cisplatin + etoposide CHT and palliative thoracic RT, when required, was the most commonly used treatment (81%) in extensive SCLC. Sixty-two percent of centers did not have endobronchial brachytherapy (EBB) facilities. There is grea...Continue Reading

References

Dec 1, 1990·International Journal of Radiation Oncology, Biology, Physics·A T Turrisi, D J Glover
Feb 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B JeremicL Djuric
Feb 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N MurrayP Dixon
Mar 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B JeremicS Milisavljevic
Jun 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J F VansteenkisteM G Demedts
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B JeremicG Radosavljevic-Asic
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K FuruseY Ariyoshi
Mar 16, 2000·Journal of the National Cancer Institute
Mar 29, 2000·CA: a Cancer Journal for Clinicians·R T GreenleeP A Wingo
Mar 29, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B JeremicL Tadic
Feb 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C FidanerD M Parkin
Mar 21, 2002·Clinics in Chest Medicine·Peter MazzoneRichard A Matthay
Jul 5, 2002·Respiration; International Review of Thoracic Diseases·Tuncay GokselUNKNOWN Turkish Thoracic Society, Lung and Pleural Malignancies Study Group
Jul 26, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·L J BillinghamM H Cullen
Nov 5, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B MovsasJ Owen
Apr 28, 2004·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Patricia TaiJake Van Dyk
May 18, 2004·International Journal of Radiation Oncology, Biology, Physics·Jeffrey A BogartUNKNOWN Cancer and Leukemia Group B study 39808
Aug 25, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Katsuyuki HottaMitsune Tanimoto
Mar 22, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Corey J LangerJ Frank Wilson
Mar 22, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Branislav Jeremic
Jun 14, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian E LallyLynn D Wilson
Feb 3, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Lucyna KepkaUNKNOWN International Atomic Energy Agency (IAEA)
Mar 3, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Takashi UnoUNKNOWN Japanese PCS Working Subgroup of Lung Cancer
May 17, 2007·Physics in Medicine and Biology·H A GayC H Sibata

❮ Previous
Next ❯

Citations

Aug 12, 2009·International Journal of Radiation Oncology, Biology, Physics·Natsuo TomitaHaruo Inokuchi
May 1, 2009·Clinical Oncology : a Journal of the Royal College of Radiologists·L KepkaB Jeremic

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.